QA: Myriad Genetics INC in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899923_2022_Myriad_Genetics_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.3433038749150238, 'aggregate_val': 790400000, 'exp_sum': 588400000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 514700000, 'ResearchAndDevelopmentExpense': 85400000, 'remainder_Expenses': -11700000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.3023255813953488, 'aggregate_val': 851200000, 'exp_sum': 653600000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 537800000, 'ResearchAndDevelopmentExpense': 81900000, 'remainder_Expenses': 33900000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899923, Myriad Genetics INC

  xvar xval
0 LiabilitiesNoncurrent 84,900,000
1 LiabilitiesCurrent 240,100,000
2 remainder_Liabilities 27,900,000
3 AssetsCurrent 484,800,000
4 AssetsNoncurrent 149,100,000
5 PropertyPlantAndEquipmentNet 43,500,000
6 Goodwill 643,300,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 537,800,000
9 ResearchAndDevelopmentExpense 81,900,000
10 remainder_Expenses 231,500,000
11 remainder_Revenues 690,600,000
12 remainder_NetIncome 133,400,000
13 remainder_ComprehensiveNetIncome -2,800,000
  yvar yval
0 Liabilities 352,900,000
1 Assets 1,320,700,000
2 Expenses 851,200,000
3 Revenues 690,600,000
4 StockholdersEquity 967,800,000
5 NetIncome -27,200,000
6 ComprehensiveNetIncome -28,600,000
7 BaseVar 1,675,800,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.55
9 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time